Which companies overlap with Joint Authority for Päijät-Häme Social and Health Care's portfolio?

Top competitors by shared drug class: Biofrontera Bioscience GmbH, DUSA Pharmaceuticals, Inc., Galderma R&D, National Cancer Center, Korea, Photocure.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/joint-authority-for-p-ij-t-h-me-social-and-health-care.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-18 · How we verify

Joint Authority for Päijät-Häme Social and Health Care — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Joint Authority for Päijät-Häme Social and Health Care pipeline: 3 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

3 marketed 0 filed 0 Phase 3 0 Phase 2 4 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Methylaminolevulinate cream	Methylaminolevulinate cream	marketed
BF-200 ALA cream	BF-200 ALA cream	marketed	Photodynamic therapy agent	Protoporphyrin IX (photosensitizer generated from aminolevulinic acid)	Dermatology/Oncology
Methyl 5-aminolevulinate	Methyl 5-aminolevulinate	marketed

Therapeutic area mix

Dermatology/Oncology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Biofrontera Bioscience GmbH · 1 shared drug class
DUSA Pharmaceuticals, Inc. · 1 shared drug class
Galderma R&D · 1 shared drug class
National Cancer Center, Korea · 1 shared drug class
Photocure · 1 shared drug class
Psoriasis Treatment Center of Central New Jersey · 1 shared drug class
Steba Biotech S.A. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Joint Authority for Päijät-Häme Social and Health Care:

Cite this brief

Drug Landscape (2026). Joint Authority for Päijät-Häme Social and Health Care — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/joint-authority-for-p-ij-t-h-me-social-and-health-care. Accessed 2026-05-18.